PT-141 (Bremelanotide): Melanocortin Receptor Research
Peptide Profiles — 2026-04-18
PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide and analog of alpha-MSH. Unlike most compounds in sexual health research, which act on vascular or hormonal targets, PT-141 works centrally through the melanocortin system.
Mechanism of Action
PT-141 acts primarily as an agonist at melanocortin-4 receptor (MC4R) and to a lesser degree MC3R:
- Centrally mediated activation rather than peripheral vascular effects
- Acts on hypothalamic circuits involved in sexual motivation
- Affects dopaminergic signaling in reward pathways
- Independent of nitric oxide or cGMP pathways
This central mechanism differentiates PT-141 from vasodilator-based compounds.
Studied Benefits
Sexual Function Research
PT-141 is one of the few peptides with extensive clinical data in sexual response:
- Research in hypoactive sexual desire disorder (HSDD)
- Studies of arousal and desire components separately from physical response
- Both male and female research populations
- Effects observed even without arousing stimuli (non-responders to peripheral agents)
Cognitive Research
Melanocortin system activation has been explored for:
- Attention and executive function research
- Memory consolidation studies
- Motivation and reward circuitry
Anti-Inflammatory Research
The melanocortin system is a major anti-inflammatory pathway:
- Studies in neuroinflammation models
- Reduced cytokine production in immune challenge research
- Protective effects in ischemia-reperfusion models
Appetite and Body Weight
MC4R is a key regulator of energy balance:
- Research on appetite suppression
- Potential applications in obesity models
- Interactions with leptin signaling
Administration and Research Use
PT-141 has been studied via multiple routes:
- Subcutaneous injection — Most common in research protocols
- Intranasal — Used in some earlier studies
- On-demand dosing — Effects are relatively rapid and time-limited
Research Considerations
Effects typically observed within 1-3 hours of administration
Dose-dependent response with transient side effects (nausea, flushing) at higher doses
Transient blood pressure changes noted in some studies
Store lyophilized at -20°C; reconstitute with bacteriostatic water
Not recommended for studies requiring sustained 24-hour exposure due to pharmacokinetics
Disclaimer: All information presented in this article is for educational and informational purposes only. Platinum Biolabs does not promote or endorse the use of peptides for human consumption. All products sold by Platinum Biolabs are intended strictly for laboratory and research use only. Consult a qualified healthcare professional before making any health-related decisions.